Bionano genomics stock

bionano genomics stock

What does BioNano genomics do for its shareholders?

Overview. Bionano Genomics, Inc. (NASDAQ: BNGO) seeks to enhance shareholder value not only through exceptional business performance and practices, but also through responsible and effective communication with its shareholders. The latest company information relevant to the individual and institutional investor includes stock price and history,...

What does BioNano do for a living?

About Bionano GenomicsBionano is a genome analysis company providing tools and services based on its Saphyr system to scientists and clinicians conducting genetic research and patient testing, and providing diagnostic testing for those with autism spectrum disorder (ASD) and other neurodevelopmental disabilities through its Lineagen business.

Who is the CEO of BioNano?

Mark holds a bachelor’s degree in electrical engineering and a master’s degree in computer and systems engineering from Rensselaer Polytechnic Institute in New York. Richard joined Bionano as Chief Business Officer in June 2021. Richard has over two decades of experience in life sciences, focused on healthcare.

How did BioNano’s 6th consecutive quarter beat the street?

First off, for the 6th consecutive quarter, Bionano posted a beat on the top-line, with revenue increasing by 112% year-over-year to $4.7 million vs. t Bionano Genomics, Inc. (BNGO) delivered earnings and revenue surprises of -16.67% and 16.38%, respectively, for the quarter ended September 2021.

Why BioNano genomics?

Bionano Genomics, Inc. (NASDAQ: BNGO) seeks to enhance shareholder value not only through exceptional business performance and practices, but also through responsible and effective communication with its shareholders.

Who are BioNano genomicstop shareholders?

Top institutional shareholders include BlackRock Inc. (6.28%), Geode Capital Management LLC (1.62%), Bank Julius Baer & Co. Ltd Zurich (1.38%), Mitsubishi UFJ Kokusai Asset Management Co. Ltd. (0.40%), Bank of New York Mellon Corp (0.35%) and Morgan Stanley (0.24%). View institutional ownership trends for Bionano Genomics.

When is BioNano GenomicsNext quarterly earnings announcement?

Bionano Genomics is scheduled to release its next quarterly earnings announcement on Tuesday, March 22nd 2022. View our earnings forecast for Bionano Genomics. How were Bionano Genomics earnings last quarter? Bionano Genomics, Inc. (NASDAQ:BNGO) released its quarterly earnings data on Thursday, November, 4th.

What are the price targets for BioNano genomicsstock?

3 brokerages have issued 1 year price targets for Bionano Genomics shares. Their forecasts range from $10.00 to $15.00. On average, they expect Bionano Genomics stock price to reach $12.33 in the next year.

Postagens relacionadas: